Neuronetics chases new depression approval; DiaGenic tanks on Alzheimer's Dx failure;

@FierceMedDev: Intuitive doubles stock buyback to quell investor angst. Article | Follow @FierceMedDev

@MarkHFierce: Haemonetics lost money in FY 2014 Q1 - Manufacturing reorg and M&A costs contributed. Yesterday's story | Follow @MarkHFierce

@DamianFierce: In case you missed it last night: GE Healthcare is recalling scanners after patient crushed to death in U.S. Report | Follow @DamianFierce

 @MichaelGFierce: NeuroSigma to begin PhIII epilepsy device trial. ICYMI yesterday | Follow @MichaelGFierce

> Neuronetics has kicked off a clinical trial to test how well its NeuroStar brain-stimulation device can treat women with postpartum depression. More

> Norwegian diagnostics outfit DiaGenic ($DIAG) watched its shares plummet more than 50% after its Alzheimer's test failed to meet its endpoints in a study. Article

> Life Technologies ($LIFE) has signed a 5-year deal with the FDA to use its diagnostics technology for food safety testing. News

> Regions in India are beginning to ban the use of mercury-based medical products. Story

> Implant Sciences has moved into much larger headquarters and manufacturing space in Wilmington, MA. Item

> EPGL Medical says it has developed a self-powered, self-contained power source for contact lenses that could enable, in part, the display of medical data such as blood sugar or oxygen levels. Item

> Conspiracy theories are mushrooming regarding the unexpected death of Barnaby Jack, a computer hacker who demonstrated security flaws in insulin pumps and other medical devices. Story

> Philips Healthcare ($PHG) is looking to establish an incubator for medical startups in Israel. Story

Biotech News

@FierceBiotech: PR: Adocia, Eli Lilly end collaboration; Adocia reacquires exclusive development rights to insulin analog. Release | Follow @FierceBiotech

@RyanMFierce: UPDATED: Foundation Medicine seeks $86.3M IPO amid chase for reimbursement. Item | Follow @RyanMFierce

@EmilyMFierce: Novavax joins H7N9 vaccine race, reports positive preclinical data. Article | Follow @EmilyMFierce

> Sanofi, NEA team up in $18M round for rare disease outfit Edimer. Story

> Celgene inks $11M inflammation deal with Array BioPharma. News

> Synta Pharma rebounds on early results from drug study for breast cancer. Article

Pharma News

@FiercePharma: ICYMI: Pfizer to split operations three ways. Yesterday's story | Follow @FiercePharma

@CarlyHFierce: India's Cadila Pharma selects site for $150M plant in Russia. Article | Follow @CarlyHFierce

> Suffering from generic onslaught, Merck cuts sales forecast. Story

> Sanofi's bid for more OTC meds gets FDA boost. Article

> Moody's cuts GlaxoSmithKline outlook, citing billions in outlays. Report

Biotech Research News

@EmilyMFierce: UCLA team IDs anti-amyloid compounds to treat Alzheimer's, other brain diseases. Story | Follow @EmilyMFierce

> Novavax joins H7N9 vaccine race, reports positive preclinical data. News

> Antibody effective at fighting norovirus in chimps. Story

> Novavax joins H7N9 vaccine race, reports positive preclinical data. Article

> Antibody effective at fighting norovirus in chimps. More

Pharma Manufacturing News

@EricPFierce: Lawmakers want assurances Smithfield sale to China's Shuanghui won't leave US drugmakers short of heparin. Report | Follow @EricPFierce

> Cadila Pharma selects site for $150M Russian plant. News

> Alexion adding 50 jobs in Ireland to grow global supply chain. Item

> Pfizer says investments in Ireland position plants for growth. More

> New Russian company to build $85M plant. Story

> Bristol-Myers turns to Samsung for cancer drug. Article

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.